John Aunins, PhD

Dr. Aunins led our first ARC Seminar about the Development of Live Bacterial Therapeutics. Many antibiotics cause damage to our microbiome, the balance of which is crucial for maintaining our health and protecting us from opportunistic pathogens. Even probiotic treatments aren't sufficient to protect against the non-specific killing of any susceptible microbe.

Currently serving as the Executive Vice President of Bioprocess & Manufacturing and CTO at Seres Therapeutics, Dr. Aunins works to do his part to revolutionize treatment of infectious disease.